Incidence of COVID-19-associated mucormycosis in COVID-19 patients after discharge from the COVID-19 hospital
Background: There are studies available on the prevalence of coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) in hospitalized patients but not on the incidence of CAM in post-discharge patients. The aim of our study was to find the incidence of CAM in the patients discharged from a...
Saved in:
Main Authors: | Aayush Kulshrestha (Author), Richa Aggarwal (Author), Parul Kodan (Author), Yudhyavir Singh (Author), Rakesh Kumar (Author), Kapil D Soni (Author), Purva Mathur (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mucormycosis in COVID-19
by: Vasantha Kamath, et al.
Published: (2021) -
COVID-19 and mucormycosis: A black fungus disaster?
by: Suchira Chillana, et al.
Published: (2022) -
Secondary infections in COVID-19: Antemortem and postmortem culture study
by: Vandana V Kiro, et al.
Published: (2024) -
Mucormycosis and COVID-19 coinfection in kidney transplant recipient
by: Prit Pal Singh, et al.
Published: (2023) -
COVID-19 and mucormycosis (Black Fungus): An epidemic within the pandemic
by: Ramandeep Singh Gambhir, et al.
Published: (2021)